Cross-presentation by intercellular peptide transfer through gap junctions

Nature

Volumn 434, Issue 7029, 2005, Pages 83-88

  Neijssen, Joost ^a   Herberts, Carla ^a   Drijfhout, Jan Wouter ^b   Reits, Eric ^a   Janssen, Lennert ^a   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOCOMPATIBILITY; CELL CULTURE; CYTOLOGY; HISTOLOGY; MOLECULAR DYNAMICS; MOLECULAR STRUCTURE; TUMORS;

HISTOCOMPATIBILITY COMPLEX (MHC); MOLECULAR MASS; PEPTIDE COUPLING; PEPTIDE TRANSFER;

PROTEINS;

CONNEXIN 43; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; HLA A2 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDASE; UBIQUITIN; CALCEIN; FLUORESCEIN DERIVATIVE; PEPTIDE; PEPTIDE HYDROLASE; VIRUS ANTIGEN;

MEDICINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BYSTANDER EFFECT; CELL TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GAP JUNCTION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; CELL CULTURE; CELL JUNCTION; CHEMISTRY; CYTOLOGY; DIFFUSION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; ORTHOMYXOVIRUS; TUMOR CELL LINE;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; BYSTANDER EFFECT; CELL LINE, TUMOR; CELLS, CULTURED; CONNEXIN 43; CYTOPLASM; DIFFUSION; FLUORESCEINS; GAP JUNCTIONS; HLA-A2 ANTIGEN; HUMANS; MOLECULAR WEIGHT; MONOCYTES; ORTHOMYXOVIRIDAE; PEPTIDE HYDROLASES; PEPTIDES; PROTEIN TRANSPORT; T-LYMPHOCYTES, CYTOTOXIC;

EID: 14544292915     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03290     Document Type: Article

References (30)

1. Yewdell, J. W., Reits, E. & Neefjes, J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nature Rev. Immunol. 3, 952-961 (2003).
2. Rock, K. L. The ins and outs of cross-presentation. Nature Immunol. 4, 941-943 (2003).
3. Ackerman, A. L. & Cresswell, P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nature Immunol. 5, 678-684 (2004).
4. Heath, W. R. et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26 (2004).
5. Segretain, D. & Falk, M. M. Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim. Biophys. Acta 1662, 3-21 (2004).
6. Goldberg, G. S., Valiunas, V. & Brink, P. R. Selective permeability of gap junction channels. Biochim. Biophys. Acta 1662, 96-303 (2004).
7. Warn-Cramer, B. J. & Lau, A. F, Regulation of gap junctions by tyrosine protein kinases. Biochim. Biophys. Acta 1662, 81-95 (2004).
8. Oviedo-Orta, E. & Evans, W. H. Gap junctions and connexin-mediated communication in the immune system. Biochim. Biophys. Acta 1662, 102-112 (2004).
9. Goldberg, G. S. & Lau, A. F. Dynamics of connexin43 phosphorylation in pp60v-src-transformed cells. Biochem. J. 295, 735-742 (1993).
10. Esinduy, C. B., Chang, C. C., Trosko, J. E. & Ruch, R. J. In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: requirement for gap functional intercellular communication. Carcinogenesis 16, 915-921 (1995).
11. Fischer, N. O., Mbuy, G. N. & Woodruff, R. I. HSV-2 disrupts gap functional intercellular communication by mammalian cells in vitro. J. Virol. Methods 91, 157-166 (2001).
12. Oelze, I., Kartenbeck, J., Crusius, K. & Alonso, A. Human papilomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69, 4489-4494 (1995).
13. Mesnil, M. & Yamasaki, H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60, 3989-3999 (2000).
14. Giepmans, B. N., Hengeveld, T., Postma, F. R. & Moolenaar, W. H. Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. J. Biol. Chem. 276, 8544-8549 (2001).
15. Reits, E. et al. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18, 97-108 (2003).
16. Harks, E. G. et al. Besides affecting the intracellular calcium signaling, 2-APB reversibly blocks gap junctional coupling in confluent monolayers. FASEB J. 17, 941-943 (2003).
17. Princiotta, M. F. et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343-354 (2003).
18. Eugenin, E. A., Branes, M. C., Berman, J. W. & Saez, J. C. TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J. Immunol. 170, 1320-1328 (2003).
19. Savinov, A. Y., Wong, F. S., Stonebraker, A. C. & Chervonsky, A. V. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8 + T cells. J. Exp. Med. 197, 643-656 (2003).
20. Kurts, C., Heath, W. R., Carbone, F. R., Kosaka, H. & Miller, I. E Cross-presentation of self antigens to CD8 + T cells: the balance between tolerance and autoimmunity. Novartis Found. Symp. 215, 172-181 (1998).
21. Li, Z., Menoret, A. & Srivastava, P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol. 14, 45-51 (2002).
22. Gromme, M. et al. Recycling MHC class 1 molecules and endosomal peptide loading. Proc. Natl Acad. Sci. USA 96, 10326-10331 (1999).
23. Gil-Torregrosa, B. C. et al. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34, 398-407 (2004).
24. Guermonprez, P. et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402 (2003).
25. Houde, M, et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402-406 (2003).
26. Serna, A., Ramirez, M. C., Soukhanova, A. & Sigal, L. J. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171, 5668-5672 (2003).
27. Wolkers, M. C., Brouwenstijn, N., Bakker, A. H., Toebes, M. & Schumacher, T. N. Antigen bias in T cell cross-priming. Science 304, 1314-1317 (2004).
28. Norbury, C. C. et al. CD8 + T cell cross-priming via transfer of proteasome substrates. Science 304, 1318-1321 (2004).
29. Shen, L. & Rock, K. L. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl Acad. Sci. USA 101, 3035-3040 (2004).
30. Verra, N. C. et al. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice. Cancer Res. 64, 2153-2161 (2004).